Evidence-Based Electronic Health Records Can Help Tackle the ‘Crisis of Variation,' According to New Elsevier Issue Brief

EBM experts identify challenges, solutions in using EHRs to orchestrate population health management, patient engagement, meaningful use and value-based accountable care

Philadelphia, PA, May 1, 2014

Elsevier, a world-leading provider of scientific, technical and medical information products and services, recently announced the availability of the second in a series of issue briefs on evidence-based medicine (EBM). The issue brief, "Closing the Gaps in EHR Evidence and Guidelines: An Agenda for Change," reveals challenges with using electronic health records (EHRs) and how developing smarter EHRs that incorporate EBM will deliver myriad benefits to both patients and healthcare providers.

The issue brief, which highlights the insights of six of the EBM experts who presented at the Health Care Leadership Forum, "Evidence at the Center of Care," in Chicago, notes that EHRs are stymied by incomplete evidence and impractical, imprecise guidelines. It identifies a "widespread crisis of variation" as a result of EHR overuse, underuse and misuse. But John D. Halamka, MD, MS, CIO at Beth Israel Deaconess Medical Center, predicts that, "EHRs have a rosy future, and leaders will continue to bridge the gap between data expectations and EHR capabilities. Clinical guidelines and rules will grow in sophistication, with the result being an increasingly directive form of EBM that more closely adheres to the thought processes of clinicians."

The issue brief also highlights suggestions from the EBM experts on building a smarter EHR and furthering the mission of evidence-based practice, including:

The issue brief is available for download at http://info.clinicalkey.com/thoughtleadership/. Subsequent issues will focus on EBM implementation and the future of EBM.

---

About Elsevier

Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence, and ClinicalKey — and publishes nearly 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.

The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media contact
Christopher Capot
Director, Corporate Relations
Elsevier
+1 212 633 3164
c.capot@elsevier.com